PhoenixBio PhoenixBio (株式会社フェニックスバイオ) is a company that provides contract study services for drug discovery and development. | ![]() FibroGen FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs. | ![]() CanSino Biologics CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases. | |
Founding Date | Founding Date 2002 | Founding Date 1993 | Founding Date 2009 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Higashihiroshima, JP HQ New York, US | Locations San Francisco, US HQ | Locations Tianjin, CN HQ |
Employees | Employees 70 | Employees 53115% increase | Employees 1,10526% decrease |
Valuation ($) | Valuation ($) 10.9 m | Valuation ($) 30.7 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) ¥1.6b (FY, 2026) | Revenue (est.) $6.4m (FY, 2025) | Revenue (est.) ¥1.1b (FY, 2025) |
Cost of goods | Cost of goods ¥342.7m (FY, 2026) | Cost of goods $556k (FY, 2025) | Cost of goods ¥81.4m (FY, 2025) |
Gross profit | Gross profit ¥1.2b (FY, 2026) | Gross profit $5.9m (FY, 2025) | Gross profit ¥1.1b (FY, 2025) |
Net income | Net income ¥125.2m (FY, 2026) | Net income $183.5m (FY, 2025) | Net income ¥27.9m (FY, 2025) |

FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs.
View company
CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases.
View company